PHASE II
Clinical trials for PHASE II explained in plain language.
Never miss a new study
Get alerted when new PHASE II trials appear
Sign up with your email to follow new studies for PHASE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug imetelstat targets rare blood cancer in phase 2 trial
Disease control Not yet recruitingThis Phase 2 trial tests the drug imetelstat in 30 adults with myelodysplastic/myeloproliferative neoplasms (MDS/MPN), a rare blood cancer. The goal is to see if imetelstat can help control the disease and to check for side effects. Participants receive the drug by IV, and the st…
Matched conditions: PHASE II
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New hope for rare kidney cancer: drug trial targets tough tumors
Disease control Not yet recruitingThis study tests a drug called sacituzumab tirumotecan in 20 people with a rare and aggressive kidney cancer (SMARCB1-deficient renal medullary carcinoma) that has worsened after at least one prior treatment. The goal is to see if the drug can shrink or control the cancer. Resear…
Matched conditions: PHASE II
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC